US Broker Ratings

Quhuo Limited (QH) Stock Analysis: Navigating a Challenging Landscape with a 52-Week Range Swing

Quhuo Limited, trading under the symbol QH, is a compelling entity within the technology sector, particularly in the software application industry. Based in Beijing, China, Quhuo operates a gig economy..

Varex Imaging Corporation (VREX) Stock Analysis: Exploring a 33% Upside Potential

Varex Imaging Corporation (NASDAQ: VREX) stands at a unique juncture for investors looking to tap into the healthcare sector, particularly in the medical devices industry. With its headquarters in Salt..

Nyxoah SA (NYXH) Stock Analysis: Unveiling a 126% Potential Upside in Sleep Apnea Solutions

Investors seeking opportunities in the healthcare sector might find Nyxoah SA (NASDAQ: NYXH) an intriguing prospect. The Belgium-based medical technology company specializes in innovative solutions for obstructive sleep apnea (OSA),..

Kaltura, Inc. (KLTR) Stock Analysis: A 151.8% Potential Upside in the Tech Sector

Kaltura, Inc. (NASDAQ: KLTR) is a noteworthy player in the technology sector, specializing in Software-as-a-Service (SaaS) and Platform-as-a-Service (PaaS) solutions. With a market cap of $214.74 million, the company is..

Health Catalyst, Inc (HCAT) Stock Analysis: Exploring the 118.93% Potential Upside for Opportunistic Investors

Health Catalyst, Inc. (NASDAQ: HCAT), a prominent player in the healthcare information services industry, is generating buzz among investors with a staggering potential upside of 118.93%. As the company navigates..

Anbio Biotechnology (NNNN) Stock Analysis: What Investors Should Know About This German IVD Innovator

Anbio Biotechnology, trading under the ticker NNNN, might not be a household name yet, but its presence in the medical instruments and supplies industry is notable. The company operates out..

Cartesian Therapeutics, Inc. (RNAC) Investor Outlook: Unpacking a 435.71% Potential Upside in Biotech

Cartesian Therapeutics, Inc. (NASDAQ: RNAC), a clinical-stage biotechnology innovator, is making waves in the healthcare sector with its cutting-edge mRNA cell therapies targeting autoimmune diseases. While the company is still..

Agora, Inc. (API) Stock Analysis: Unpacking a 23.68% Potential Upside for Investors

Agora, Inc. (NASDAQ: API), a noteworthy player in the technology sector, has garnered the attention of investors looking to capitalize on its potential upside. With a market capitalization of $429.13..

TotalEnergies SE (TTE) Stock Analysis: Assessing the Investment Potential Amidst a 5.05% Dividend Yield

TotalEnergies SE (TTE), a French multinational energy company, presents an intriguing opportunity for investors navigating the dynamic landscape of the energy sector. With a market capitalization of $165.69 billion, TotalEnergies..

CS Disco, Inc. (LAW) Stock Analysis: Is the 180% Upside Potential Worth the Risk?

CS Disco, Inc. (NYSE: LAW), a leading provider of cloud-native and AI-powered legal solutions, is drawing attention from investors with its impressive potential upside of 180.47%. Despite currently trading at..

XOMA Royalty Corporation (XOMA) Stock Analysis: Unlocking a Potential 164.89% Upside with Strategic Biotech Ventures

XOMA Royalty Corporation (NASDAQ: XOMA) presents a compelling opportunity for investors seeking exposure to the biotechnology sector, particularly through its unique business model of royalty aggregation. With its current market..

ZoomInfo Technologies Inc. (GTM) Stock Analysis: Exploring a 40.75% Potential Upside for Savvy Investors

ZoomInfo Technologies Inc. (NASDAQ: GTM) stands out in the competitive technology sector with a compelling potential upside of 40.75%, an attractive figure for investors seeking growth opportunities in the software..

AppLovin Corporation (APP) Stock Analysis: Assessing a 65% Potential Upside Amid Strong Buy Ratings

AppLovin Corporation (NASDAQ: APP) stands out in the communication services sector, specifically within the advertising agencies industry, with a compelling investment narrative fueled by its robust software-based advertising platform. Founded..

Marti Technologies, Inc. (MRT) Stock Analysis: 138% Potential Upside Beckons Investors

Marti Technologies, Inc. (NASDAQ: MRT), a burgeoning player in Turkey’s technology sector, is capturing investor attention with its impressive growth metrics and promising analyst ratings. Despite its current trading price..

NICE Ltd (NICE) Stock Analysis: A 61.76% Potential Upside with Strong Buy Ratings

NICE Ltd (NASDAQ: NICE), an Israeli technology company renowned for its AI-powered cloud platforms, is currently capturing the attention of individual investors due to its promising growth potential. Operating within..

Cidara Therapeutics, Inc. (CDTX) Stock Report: Navigating a Biotech Trail with a Market Cap of $6.96 Billion

Cidara Therapeutics, Inc. (NASDAQ: CDTX), a San Diego-based biotechnology firm, is carving its niche in the healthcare sector by focusing on innovative therapies for critical diseases. With a noteworthy market..

SANUWAVE Health, Inc. (SNWV)

⚠️ No article content returned.

..

TruBridge, Inc. (TBRG): Investor Outlook and Potential 12.77% Upside in the Healthcare Information Services Sector

TruBridge, Inc. (NASDAQ: TBRG) is carving a niche in the rapidly expanding healthcare information services industry. With a market capitalization of $301.73 million, the company is positioned within the healthcare..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Unveiling a Potential 338% Upside in the Biotechnology Arena

aTyr Pharma, Inc. (NASDAQ: ATYR), a clinical-stage biotechnology company, is capturing investor attention with its potential for significant upside. The company’s focus on pioneering therapies in fibrosis and inflammation positions..

Canopy Growth Corporation (CGC) Investor Outlook: Exploring the 56% Potential Upside

In the bustling world of cannabis, Canopy Growth Corporation (NASDAQ: CGC) stands out as a pioneering entity that continues to capture investor interest despite facing significant financial challenges. Headquartered in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds